Aller au contenu principal
Profil bibliographique

C Antoci

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

2Publications signalées
0Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Inflammatory Bowel DiseasePsoriasis: Treatment and PathogenesisBiosimilars and Bioanalytical Methods

Les publications récentes

2026 conference-abstract OpenAlex

P1003 Effectiveness of Mirikizumab as induction therapy in ulcerative colitis -a prospective multicentre real-life study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

G Costantino, Anna Viola, A Iuculano, R Li Voti et autres

Abstract Background Mirikizumab (MIRI), a monoclonal IgG4 antibody against the p19 subunit of Interleukin 23 was recently licensed for the treatment of ulcerative colitis (UC). Most data come from the pivotal trials but real-life data are scant. The purpose of the present …

it, ar, es (code pays fourni par la source)

0 citations Journal of Crohn s and Colitis
2026 conference-abstract OpenAlex

P0843 Effectiveness and safety of induction therapy with Mirikizumab in older patients with ulcerative colitis compared to younger adults - a prospective multicentre real-life study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Anna Viola, G Costantino, A Iuculano, R Li Voti et autres

Abstract Background Subjects aged ≥60 years represent an increasing population of patients with ulcerative colitis (UC). Beyond the questions concerning effectiveness of new therapies in this population, the aspects of safety remain the primary concern. In this special population, the only data …

it, ar, es (code pays fourni par la source)

0 citations Journal of Crohn s and Colitis

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.